RutledgeK. A., McDonaldH. P.jr.: Costs of treating simple nosocomial urinary tract infection. Urology, 26; suppl. 1, 24 (1985).
2.
HandW. L., SmithJ. W., SanfordJ. P.: The antibacterial effect of normal and infected urinary bladder. J. Lab. Clin. Med., 77; 605 (1971).
3.
RobinsonM. R. G., ArudpragasamS. T., SahgalS. M., CrossR. J., AkdasA., FittalB., SibbadR.: Bacteraemia resulting from prostatic surgery: the source of bacteria. Brit. J. Urol., 54; 542 (1982).
4.
CafferkeyM. T., FalkimerF. R., GilespieW. A., MurphyD. M.: Antibiotics for the prevention of septicaemia in urology. J. Antimicr. Chemother., 9; 471 (1982).
5.
BrooksM.: Septicaemia following transurethral resection of the prostate. Letter to the Editor. J. Urol., 136; 920 (1986).
6.
MorrisM. A., GolovskyD. G., GuinnessM. D. G., MaherP. O.: The value of prophylactic antibiotics in transurethral prostatic resection: a controlled trial with observation on the origin of postoperative infection. Brit. J. Urol., 48; 479 (1976).
7.
LucyS. S., DrachG. W., CoxC. E.: Incidence of infection after prostatectomy and efficacy of cephaloridine prophylaxis. J. Urol., 105; 836 (1971).
8.
ShapiroS. R., SantamarinaA., HarrisonJ. M.: Catheter-associated urinary tract infections: incidence and new approach to prevention. J. Urol., 112; 659 (1974).
9.
JackmanF. R., ChisholmG. D.: Urinary infections and prostatectomy. Brit. J. Urol., 47; 547 (1975).
10.
BottoH., RichardF., MatheiuF., PerrauA. M., CarneyM.: Short-term prophylax's with cefotaxime in prostatic surgery. J. Antimicr. Chemother., Suppl. B, 14; 231 (1984).
11.
FalkinerF. R., MaP. T. S., MurphyD. M., CafferkeyM. T., GillespieW. A.: Antimicrobial agents for the prevention of urinary tract infection in transurethral surgery. J. Urol., 129; 766 (1983).
12.
KuninC. M., McCormackR. C.: Prevention of catheter induced urinary tract infections by sterile close drainage. N. Engl. J. Med., 742; 1155 (1966).
13.
WarrenJ. W., PlattR., ThomasR. J., RosmerB., KassE. H.: Antibiotic irrigation and catheter-associated urinary tract infections. N. Engl. J. Med., 299; 570 (1978).
14.
GrabeM., HellstemS.: Long-term follow-up after transurethral prostatic resection with or without a short peri-operative antibiotics course. Brit. J. Urol., 57; 444 (1985).
15.
NordenstamG. R., BrandbergC. A., OdenA. S., SvanborgEdèn C. M., SvanborgA.: Bacteriuria and mortality in an elderly population. N. Engl. J. Med., 314; 1152 (1986).
16.
DontasA. S., Kasviki-CharvatiP., PanamayiotouC. P., MarketosS. G.: Bacteriuria and survival in old age. N. Engl. J. Med., 304; 939 (1981).
GrabeM., ForsgrenA., HellstenS.: The effectiveness of a short perioparative course with pivampicillin/pivmecillinam in transurethral prostatic resection: clinical results. Bacteriological results. Scand. J. Infect. Dis., 18; 567 (1986).
19.
PlordeS. S., KennedyR. P., BourneH. H., AnsellJ. S., PedersdorfR. G.: Course and prognosis of prostatectomy: with a note on the incidence of bacteriemia and effectiveness of chemoprophylaxis. N. Engl. J. Med., 272; 269 (1965).
20.
KuninC. M.: Detection, prevenction and management of urinary tract infections, p. 104, 109, 118 e 120, Lea & Febiger, Philadelphia 1972.
21.
GensterH. G., MadsenP. O.: Urinary tract infections following transurethral prostatectomy: with special reference to the use of antimicrobials. J. Urol., 104; 163 (1970).
22.
FinkelsteinL. H., ArshTD. B., ManfreyS. J., ChildsS.: Ceftriaxone in the prevention of postoperative infection in patients undergoing transurethral resection of the prostate. Amer. J. Surg., 148; 19 (1984).
23.
PeritiP., NovelliA., RealiE. F., LamannaS., FontanaP.: Prophylactic chemotherapy with fosfomicin trometamol salt during transurethral prostatic surgery: a controlled multicentric clinical trial. Eur. Urol., 13; Suppl. 1, 122 (1987).
24.
HelmholzH. F.jr.: Determinaiton of the bacterial content of the urethra: a new method, with results of a study of 82 men. J. Urol., 64; 158 (1950).
25.
DanielssonD.: Infections of the male genital tract. Intern. J. Androl., Suppl. 1, 43 (1978):
26.
GrabeM., HellstemS.: Bacteriuria a risk factor in men with bladder outflow obstruction. In: Host parasite interaction in the urinary tract. C. M. Svamborg-Eden, E. H. Kass (eds.). Chicago University Press, Chicago U.S.A.
27.
ChinN. X., NeuC.: Synergy of azlocillin with aminoglycosides. J. Antimicr. Chemother., 11; Suppl. B, 33 (1983).
28.
FarellW. M., WilksM., DrasarF. A.: Synergy between aminoglycosides and semi-synthetic penicillins against gentamicin resistant Gram-negative rods. J. Antimicrob. Chemother., 5; 23 (1979).
29.
NeuH. C., FuK. J.: Synergy of azlocillin and mezlocillin combined with aminoglycoside antibiotics and cephalosporins. Antimicr. Agents Chemother., 13; 813 (1978).